Corbus Pharmaceuticals Holdings Inc

Research Corbus Pharmaceuticals Holdings Inc (CRBP) on Bullrun: market cap USD 166.38M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerCRBP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 166.38M
• Financial periodFY2025
• Net income-USD 78.54M
• Free cash flow-USD 64.50M

Valuation Snapshot

latest market cap is USD 166.38M.

About Corbus Pharmaceuticals Holdings Inc

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.

Frequently asked questions

What is Corbus Pharmaceuticals Holdings Inc's market cap?

Corbus Pharmaceuticals Holdings Inc's market capitalization is USD 166.38M.

What does Corbus Pharmaceuticals Holdings Inc do?

Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity.